Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-obesity effects of the dual-active adenosine A2A/A3 receptor-ligand LJ-4378. | Int J Obes (Lond) | 2022 | 36167764 | PubTator, text mining | PubMed |
| Generation of mega brown adipose tissue in adults by controlling brown adipocyte differentiation in vivo. | Proc Natl Acad Sci U S A | 2022 | 36161914 | PubTator, text mining | PubMed |
| The efficacy of nebivolol on spontaneously hypertensive rats with overactive bladder - an experimental study. | Arch Med Sci | 2022 | 36160351 | PubTator, text mining | PubMed |
New Moms Wellness Study: the randomized controlled trial study protocol for an intervention study to increase fruit and vegetable intake and lower breast cancer risk through weekly counseling and supplemental fruit and vegetable box delivery in breastfeeding women. | BMC Womens Health | 2022 | 36153518 | PubTator, text mining | PubMed |
| Multitargeting nature of muscarinic orthosteric agonists and antagonists. | Front Physiol | 2022 | 36148314 | PubTator, text mining | PubMed |
| Mirabegron in the Management of Overactive Bladder Syndrome. | Int J Womens Health | 2022 | 36147890 | PubTator, text mining | PubMed |
| DPP4 as a Potential Candidate in Cardiovascular Disease. | J Inflamm Res | 2022 | 36147690 | PubTator, text mining | PubMed |
| β2-Adrenergic Receptor Signaling Pathway Stimulates the Migration and Invasion of Cancer Cells via Src Activation. | Molecules | 2022 | 36144682 | PubTator, text mining | PubMed |
| Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction. | Biomedicines | 2022 | 36140279 | PubTator, text mining | PubMed |
| Effects of adrenergic-stimulated lipolysis and cytokine production on in vitro mouse adipose tissue-islet interactions. | Sci Rep | 2022 | 36138030 | PubTator, text mining | PubMed |
| Vibegron for the treatment of overactive bladder: a comprehensive update. | Expert Opin Pharmacother | 2022 | 36124780 | PubTator, text mining | PubMed |
| The evolving view of thermogenic fat and its implications in cancer and metabolic diseases. | Signal Transduct Target Ther | 2022 | 36114195 | PubTator, text mining | PubMed |
| Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape. | Front Pharmacol | 2022 | 36110544 | PubTator, text mining | PubMed |
| Targeting cancer cachexia: Molecular mechanisms and clinical study. | MedComm (2020) | 2022 | 36105371 | PubTator, text mining | PubMed |
| Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults. | Clin Pharmacol Drug Dev | 2022 | 36104302 | PubTator, text mining | PubMed |
| Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments. | PPAR Res | 2022 | 36092543 | PubTator, text mining | PubMed |
| A sensitive mitochondrial thermometry 2.0 and the availability of thermogenic capacity of brown adipocyte. | Front Physiol | 2022 | 36091398 | PubTator, text mining | PubMed |
| Differential Effect of Fat Intake on Blood Pressure in Healthy Japanese Women with and without the Variant of Fat Mass and Obesity-Associated Gene. | J Oleo Sci | 2022 | 36089400 | PubTator, text mining | PubMed |
| The Role of Neural Signaling in the Pancreatic Cancer Microenvironment. | Cancers (Basel) | 2022 | 36077804 | PubTator, text mining | PubMed |
| Obesity and cancer-extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases. | Cancer Metastasis Rev | 2022 | 36074318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=28